Nanoparticles May Offer Better Protection Against SARS-CoV-2 Variants

The first generation of COVID-19 vaccines has been very effective; however, they do have certain limits. Their effectiveness can diminish without a booster shot, and they may be less effective against certain variants.

Related Keywords

Daniel Kulp ,Yuanhan Wu ,Kyliem Konrath ,Katee Broderick ,Vivianem Andrade ,Max Crispin ,Xizhou Zhu ,Davidb Weiner ,Matthew Sullivan ,Benjamin Fry ,Jared Adolf Bryfogle ,Trevor Rf Smith ,Mansi Purwar ,Katherine Schultheis ,Himanshi Chawla ,Susannen Walker ,Emma Reuschel ,Nicholasj Tursi ,Igor Maricic ,Alan Moore ,Jesper Pallesen ,Christel Iffland ,Neethu Chokkalingam ,Ziyang Xu ,Indiana University ,Ligand Pharmaceuticals ,University Of Southhampton ,Covid Pa Department Of Human Services ,Vaccine Immunotherapy Center ,Study Co ,University Of Pennsylvania ,Inovio Pharmaceuticals ,Cure Pa Department Of Health ,Wistar Coronavirus Discovery Fund ,Wistar Institute ,Institute For Protein Innovation ,Dan Kulp ,Image Credit ,Study Corresponding Author ,Associate Professor ,Charitable Trust Professor ,Cancer Research ,Study Co Author ,Executive Vice President ,Kevin Liaw ,Drew Frase ,Ami Patel ,Protein Innovation ,Human Services ,